Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)
Is a
Health Conditions in Trial
Intervention Treatment
Patients with migraine treated with triptans, Lasmiditan or Gepants
0
Intervention Type
Drug
0
Last Updated
February 21, 2024
0
Observational Study Perspective
Prospective
0
Observational Clinical Trial Type
Cohort
0
Primary Completion Date
September 30, 2024
0
Trial Recruitment Size
1,500
0
Clinical Trial Start Date
December 4, 2023
0
Study Completion Date
December 1, 2024
0
Clinical Trial Study Type
Observational
0
NCT Number
Official Name
Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP): an International Prospective Multicentric Cohort Study
0
Official Website
Find more entities like Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.